Key result
Succinylcholine was successfully used as a muscle relaxant during 35 electroconvulsive therapy sessions in a patient with newly discovered Brugada syndrome.
Why the study?
Is succinylcholine safe to use as a muscle relaxant during electroconvulsive therapy in a patient with Brugada syndrome?
Is succinylcholine safe to use as a muscle relaxant during electroconvulsive therapy in a patient with Brugada syndrome?
This case report suggests that succinylcholine may be safely used as a muscle relaxant for electroconvulsive therapy in patients with Brugada syndrome.
May support succinylcholine for ECT in Brugada syndrome; hypothesis-generating and should not change practice.
We describe a patient with a major depression and a newly discovered Brugada syndrome, who was successfully treated with 35 electroconvulsive therapy sessions using succinylcholine as muscle relaxant. We discuss the use of succinylcholine in patients with Brugada syndrome.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (2019) studied this question. Succinylcholine was successfully used as a muscle relaxant during 35 electroconvulsive therapy sessions in a patient with newly discovered Brugada syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: